Brokerages Set Trevi Therapeutics, Inc. (NASDAQ:TRVI) Target Price at $15.94
Trevi Therapeutics, Inc. (NASDAQ:TRVI – Get Free Report) has been assigned an average recommendation of “Buy” from the ten brokerages that are currently covering the stock, Marketbeat reports. Seven research analysts have rated the stock with a buy recommendation and three have assigned a strong buy recommendation to the company. The average 12-month price objective […]
Trevi Therapeutics, Inc. (NASDAQ:TRVI – Get Free Report) has been assigned an average recommendation of “Buy” from the ten brokerages that are currently covering the stock, Marketbeat reports. Seven research analysts have rated the stock with a buy recommendation and three have assigned a strong buy recommendation to the company. The average 12-month price objective […]
